TNF and Insulin resistance: Additionally, to determine whether RBO could improve the atherogenicity and insulin resistance status through attenuation in inflammation or not, the correlation of alterations in TNF-α serum concentration (ng/L) and various indices over the 8 weeks duration of the trial was examined.